InvestorsHub Logo
Post# of 4968997
Next 10
Followers 26
Posts 1899
Boards Moderated 0
Alias Born 06/15/2007

Re: None

Tuesday, 03/07/2023 1:47:47 PM

Tuesday, March 07, 2023 1:47:47 PM

Post# of 4968997
AMRX-Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients Presented at ACC.23/WCC
DUBLIN, Ireland and BRIDGEWATER, N.J., March 06, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted new in vitro data supporting the potential mechanistic effects of eicosapentaenoic acid (EPA) in reducing cardiovascular events in at-risk patients presented at the joint ACC.23 together with the World Congress of Cardiology (ACC.23/WCC) in New Orleans, LA, March 4-6, 2023.

“The findings shared at ACC.23/WCC provide additional insight into the ....

https://healthstockshub.com/news/nasdaq/amrn/amarin-highlights-new-evidence-of-therapeutic-value-of-epa-in-reducing-cardiovascular-events-in-at-risk-patients-presented-at-acc-23-wcc

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.